Agilent Technologies (A) Stock Price

Agilent Technologies Inc is primarily active in the industries of healthcare, diagnostics, and life sciences.

Some of the main competitors of Agilent Technologies Inc in the market are Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc, and Shimadzu Corporation.

Agilent Technologies Inc. is a renowned company in the field of life sciences, diagnostics, and applied chemical markets. Founded in 1999, Agilent Technologies was a spin-off from Hewlett-Packard Company. It quickly established itself as a leading provider of measurement solutions, scientific instruments, and services. With a strong focus on innovation and cutting-edge technologies, Agilent Technologies has helped numerous industries advance through its products, collaborations, and expertise. Today, the company's diverse portfolio encompasses areas such as genomics, pharmaceuticals, environmental testing, and more. Agilent Technologies Inc. continues to contribute to scientific advancements and remains a trusted name in the industry.

Agilent Technologies Inc, a renowned industry leader, has achieved several significant milestones. Notably, in 1999, Agilent became an independent company after being spun-off from Hewlett-Packard. Since then, Agilent has continued to thrive and expand its market presence. Over the years, the company has gained recognition for its pioneering advancements in measurement solutions, such as the development of the world's first handheld digital multimeter and the establishment of breakthrough technologies for chemical analysis. Agilent's commitment to innovation has also secured numerous prestigious awards, including the R&D 100 Award. With a rich history of achievements, Agilent Technologies Inc remains at the forefront of cutting-edge technologies.

Agilent Technologies Inc is primarily present in various countries and regions across the globe. Some of the key locations where the company has a significant presence include the United States, Europe, China, Japan, and India. With its headquarters in Santa Clara, California, Agilent operates internationally, catering to customers in the fields of life sciences, diagnostics, and applied chemical markets. With a strong global footprint, Agilent has established a wide network of manufacturing facilities, sales offices, and research and development centers in these regions, enabling the company to serve its diverse customer base effectively.

Agilent Technologies Inc represents values of innovation, integrity, and collaboration. With a strong corporate philosophy rooted in customer success, Agilent aims to deliver reliable and high-quality solutions to enable scientific discoveries. The company strives for excellence in all aspects of their business, including environmental sustainability and social responsibility. Agilent fosters a culture of diversity and inclusion, promoting the empowerment of its employees and respecting the communities it serves. By consistently exceeding customer expectations and staying at the forefront of technology advancements, Agilent Technologies Inc demonstrates its commitment to driving progress and enabling advancements in life sciences, diagnostics, and applied chemical markets.

Converted at the current exchange rate, the Agilent Technologies share trades at 152.89 EUR (171.25 USD).

The Agilent Technologies share (A) is listed on 9 stock exchanges, including: NYSE (A), London (0HAV.L), SIX (Zürich) (AG8.SW), Frankfurt (AG8.F), München (AG8.MU), Düsseldorf (AG8.DU), Hamburg (AG8.HM).

Agilent Technologies Inc is a globally leading provider in the field of life sciences, diagnostics, and applied chemistry. The company offers a variety of products and solutions for the analysis, testing, and diagnosis of materials. The company is divided into various business segments. The Life Sciences and Applied Chemistry business segment offers products for the analysis of molecular information and biochemical interactions. These include chromatography columns, mass spectrometry systems, DNA and RNA synthesis reagents, microfluidic systems, and much more. These products are used in pharmaceutical research, biotechnology, the food industry, environmental analysis, and other fields. Another important business segment is diagnostics. Here, Agilent offers instrumental and reactive tools for cancer, genetic, and clinical diagnostics. The range includes in vitro diagnostic products, devices for clinical chemistry, as well as infection tests and diagnostic software. The high precision and sensitivity solutions are designed to improve the accuracy of clinical diagnoses and treatment outcomes and optimize patient care. Also available are systems for electronic testing and measurement technology. These include oscilloscopes, signal generators, network analyzers, and other devices for capturing and analyzing electrical signals used in the communication industry, automotive construction, and other industries. Agilent is also a significant supplier of consumables for laboratories. The range extends from solvents, sample vessels, pipettes, chemicals to clothing and training for laboratory employees. To deliver the range of offerings to customers, Agilent organizes its work according to regional markets. The company has over 50 locations worldwide, including research, production, and customer centers. The company pursues a strategy aimed at growth and expansion into new sectors and geographic regions. Agilent has deepened and expanded its expertise in new areas through acquisitions of companies in recent years, including highly specialized companies such as BioTek Instruments, ACEA Biosciences, and Lasergen, to name just a few. Agilent's business model is based on focusing on customer needs and providing high-quality products and services. The company relies on innovation and investments in research and development to solidify and expand its position in many markets. In addition, the company emphasizes the importance of environmental protection, social responsibility, fair competition, and employee satisfaction. All in all, Agilent is a significant provider of products and solutions for customers in various industries. The company is expected to remain a leader in the field of life sciences, diagnostics, and applied chemistry due to successful business development.

The expected revenue of Agilent Technologies is 7.50 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Agilent Technologies is 1.77 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Agilent Technologies is currently 27.52. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Agilent Technologies stock.

The price-to-sales ratio (P/S) of Agilent Technologies is currently 6.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Agilent Technologies stock.

The Eulerpool Quality Score for Agilent Technologies is 5/10.

The ISIN of Agilent Technologies is US00846U1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Agilent Technologies is 929138. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Agilent Technologies is A. The ticker symbol is used to trade Agilent Technologies shares on the stock exchange.